![Capecitabine 2-O-BDR Impurity (USP) ;2’-O-(5’-Deoxy-β-D-ribofuranosyl) Capecitabine ; [1-[5-Deoxy-2-O-(5-deoxy-β-D-ribofuranosyl)-β-D-ribofuranosyl]-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]-carbamic acid pentyl ester | 1262133-66-3](http://drjcrbio.com/wp-content/uploads/c-31.png)
Capecitabine 2-O-BDR Impurity (USP) ;2’-O-(5’-Deoxy-β-D-ribofuranosyl) Capecitabine ; [1-[5-Deoxy-2-O-(5-deoxy-β-D-ribofuranosyl)-β-D-ribofuranosyl]-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]-carbamic acid pentyl ester | 1262133-66-3
Capecitabine 2-O-BDR Impurity (USP)
Description
| Code: JCCPB-10 |
| CAS: 1262133-66-3 |
| Chemical Formula: C20H30FN3O9 |
| Molecular Weight: 475.47 |
| Category: Reference Standards/API Drug Metabolites/EP Impurities/USP Impurities |
| Literature: |
| Application: Capecitabine 2-O-BDR Impurity (USP) ;2’-O-(5’-Deoxy-β-D-ribofuranosyl) Capecitabine ; [1-[5-Deoxy-2-O-(5-deoxy-β-D-ribofuranosyl)-β-D-ribofuranosyl]-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]-carbamic acid pentyl ester | 1262133-66-3 is useful as reference Impurity standard. |
